Literature DB >> 9185868

Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice.

S Ponnazhagan1, P Mukherjee, M C Yoder, X S Wang, S Z Zhou, J Kaplan, S Wadsworth, A Srivastava.   

Abstract

Adeno-associated virus 2 (AAV), a non-pathogenic human parvovirus, is gaining attention as a vector for its potential use in human gene therapy. However, few studies have examined the safety and the efficacy of this vector system in vivo. We report here that recombinant AAV vectors, when directly injected intravenously in mice, accumulated predominantly in liver cells, suggesting that AAV may possess in vivo organ-tropism for liver. The transduced lacZ reporter gene was expressed in hepatocytes in the liver and, at the level examined, did not appear to induce any detectable cytotoxic T lymphocyte response against beta Gal. AAV-mediated transduction of murine hematopoietic progenitor cells ex vivo followed by transplantation into lethally irradiated syngeneic mice also revealed high-efficiency gene transfer into progeny cells without any observable cytotoxicity or deleterious effect. The transduced reporter gene sequences were also expressed in mice in vivo. The AAV-based vectors may thus prove useful as a potentially safe alternative to the more commonly used retrovirus- and adenovirus-based vector systems.

Entities:  

Mesh:

Year:  1997        PMID: 9185868     DOI: 10.1016/s0378-1119(96)00576-8

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  39 in total

1.  Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts.

Authors:  J Hansen; K Qing; A Srivastava
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 2.  Adeno-associated virus vectors and hematology.

Authors:  D W Russell; M A Kay
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

3.  Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts.

Authors:  J Hansen; K Qing; H J Kwon; C Mah; A Srivastava
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 4.  Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies.

Authors:  V Schmitz; C Qian; J Ruiz; B Sangro; I Melero; G Mazzolini; I Narvaiza; J Prieto
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

5.  Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors.

Authors:  Shaoyong Li; Chen Ling; Li Zhong; Mengxin Li; Qin Su; Ran He; Qiushi Tang; Dale L Greiner; Leonard D Shultz; Michael A Brehm; Terence R Flotte; Christian Mueller; Arun Srivastava; Guangping Gao
Journal:  Mol Ther       Date:  2015-09-25       Impact factor: 11.454

6.  Adeno-Associated Virus: The Naturally Occurring Virus Versus the Recombinant Vector.

Authors:  Arun Srivastava
Journal:  Hum Gene Ther       Date:  2016-01       Impact factor: 5.695

7.  Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34+ hematopoietic progenitor cells: donor variation and correlation of transgene expression with cellular differentiation.

Authors:  S Ponnazhagan; P Mukherjee; X S Wang; K Qing; D M Kube; C Mah; C Kurpad; M C Yoder; E F Srour; A Srivastava
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

8.  Biodistribution and safety profile of recombinant adeno-associated virus serotype 6 vectors following intravenous delivery.

Authors:  Daniel Stone; Ying Liu; Zong-Yi Li; Robert Strauss; Eric E Finn; James M Allen; Jeffrey S Chamberlain; André Lieber
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

9.  Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination.

Authors:  X S Wang; B Khuntirat; K Qing; S Ponnazhagan; D M Kube; S Zhou; V J Dwarki; A Srivastava
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus.

Authors:  X Xiao; J Li; R J Samulski
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.